Is Capecitabine New Standard in Pre-op Rectal Cancer?

Dr David Kerr reports on a study in which oral capecitabine beat continuous-infusion 5-FU 'fairly and squarely' in tumor control of early rectal cancer, which may prove a new standard of practice.

Source: Medscape Oncology - January 15, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts